About Eledon
Eledon is a company based in Irvine (United States) founded in 2004.. Eledon has raised $1.89 million across 7 funding rounds from investors including Orbimed and BVF Partners. The company has 31 employees as of December 31, 2024. Eledon has completed 1 acquisition, including Anelixis Therapeutics. Eledon offers products and services including Tegoprubart. Eledon operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, CareDx, Neurocrine and ADMA Biologics, among others.
- Headquarter Irvine, United States
- Employees 31 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Eledon Pharmaceuticals, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-36.18 M68.95as on Dec 31, 2024
-
EBITDA
$-70.22 M-64.73as on Dec 31, 2024
-
Total Equity Funding
$1.89 M (USD)
in 7 rounds
-
Latest Funding Round
$50 M (USD), Post-IPO
May 09, 2024
-
Investors
Orbimed
& 1 more
-
Employee Count
31
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Eledon
Eledon is a publicly listed company on the NASDAQ with ticker symbol ELDN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Eledon
Eledon offers a comprehensive portfolio of products and services, including Tegoprubart. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Antibody designed to prevent immune rejection in organ transplants.
Unlock access to complete
Unlock access to complete
Funding Insights of Eledon
Eledon has successfully raised a total of $1.89M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $50 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Post-IPO — $50.0M
-
First Round
First Round
(13 Sep 2011)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Post-IPO - Eledon | Valuation |
investors |
|
| May, 2023 | Amount | Post-IPO - Eledon | Valuation |
investors |
|
| Sep, 2020 | Amount | Post-IPO - Eledon | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Eledon
Eledon has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Orbimed and BVF Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US private equity investments are managed by BVF Partners.
|
Founded Year | Domain | Location | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Eledon
Eledon has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Anelixis Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
CD40 and SOD1 targeting drugs are developed for ALS treatment.
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Eledon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Eledon Comparisons
Competitors of Eledon
Eledon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, CareDx, Neurocrine and ADMA Biologics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Medical solutions for transplant patients are developed and provided.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Plasma-based biologics are developed for immune deficiency and infectious diseases.
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Eledon
Frequently Asked Questions about Eledon
When was Eledon founded?
Eledon was founded in 2004 and raised its 1st funding round 7 years after it was founded.
Where is Eledon located?
Eledon is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Is Eledon a funded company?
Eledon is a funded company, having raised a total of $1.89M across 7 funding rounds to date. The company's 1st funding round was a Post-IPO of $108.14M, raised on Sep 13, 2011.
How many employees does Eledon have?
As of Dec 31, 2024, the latest employee count at Eledon is 31.
What does Eledon do?
Eledon was founded in 2004 and is based in Irvine, United States. Operations focus on the biotechnology sector, where solutions for organ and cellular transplantation are provided to address autoimmune and neurodegenerative diseases. The CD40L pathway is targeted through antibodies, with AT-1501 developed for pro-inflammatory responses in autoimmune conditions, transplant rejection, and neuroinflammation. AT-2001 is also advanced for autoimmune indications.
Who are the top competitors of Eledon?
Eledon's top competitors include Jazz Pharmaceuticals, CareDx and ADMA Biologics.
What products or services does Eledon offer?
Eledon offers Tegoprubart.
Is Eledon publicly traded?
Yes, Eledon is publicly traded on NASDAQ under the ticker symbol ELDN.
How many acquisitions has Eledon made?
Eledon has made 1 acquisition, including Anelixis Therapeutics.
Who are Eledon's investors?
Eledon has 2 investors. Key investors include Orbimed, and BVF Partners.
What is Eledon's ticker symbol?
The ticker symbol of Eledon is ELDN on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.